{"anticipatedPostingDate":"2027-02","denomUnitsSelected":"Participants","description":"Progression-free survival 2 (PFS2) is defined as the time from randomization to disease progression (radiographic or symptomatic progression as determined by the investigator) on the next line of treatment or death from any cause in the absence of observed disease progression. If the participant is alive at the cutoff for analysis, and disease progression has not been observed, PFS2 data will be censored on the latest date of last progression-free assessment or start of the next line of treatment.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline","title":"PFS2 by Investigator","type":"SECONDARY"}